Baku 17° C
COVID vaccine manufacturers to make billions from selling third dose
Business
- 26 September, 2021
- 07:43
Pfizer may receive $26 billion from the sales of the third dose of its coronavirus vaccine in 2022, Report informs with reference to the Morningstar financial company.
The company's sales forecast for this year is $4 billion.
Another vaccine maker, Moderna, might earn $2 billion this year and $14 billion next year.
At the same time, Morningstar analysts believe that sales might increase significantly next year as countries approve the third dose.
Author
Latest News
10:12
Vietnam appoints first female Deputy Prime Minister
Other countries09:55
Trump oversees Thailand-Cambodia peace deal as Asia tour gets under way
Other countries09:45
EU to reduce dependence on Chinese rare earths
Other countries09:25
North Korea's foreign minister to visit Russia and Belarus, KCNA says
Other countries09:16
Pakistan seizes narcotics worth over $64M in major anti-smuggling operation
Other countries17:54
Leftwinger Catherine Connolly to be Ireland's next president after landslide election victory
Other countries17:48
One of Iran's largest private banks bankrupt
Region17:45
Media: White House pressuring Congress to repeal Caesar Act on Syria
Other countries17:43